Results 71 to 80 of about 236,804 (100)

Comparison of the Efficacy of Biosimilar G-CSF Molecules in the Prevention of Chemotherapy-Induced Neutropenia in Breast Cancer Patients Receiving Adjuvant Docetaxel-Cyclophosphamide Combination Treatment

open access: yesJournal of Oncological Sciences
Objective: Adjuvant chemotherapy is one of the most crucial factors in reducing recurrence risk in early-stage breast cancer. The docetaxel-cyclophosphamide (TC) protocol is among the most frequently used regimens in adjuvant therapy.
Ekin Konca KARABUĞA   +2 more
doaj   +1 more source

Predictors of Chemotherapy Induced Neutropenia in Patients with Breast Cancer

open access: yesJournal of Oncological Sciences
Objective: Chemotherapy induced neutropenia (CIN) is a common adverse effect of chemotherapy and interferes with optimal dosing. The purpose of this study was to determine the frequency and risk factors of grade 3/4 CIN (absolute neutrophil count
Alper SARI   +2 more
doaj   +1 more source

Defining and sparing sexual function-related organs at risk for rectal cancer radiotherapy

open access: yesActa Oncologica
Background and purpose: Sexual dysfunction is a common consequence of pelvic radiotherapy, influenced by psychological, physical, social, and relational factors.
Camilla J S Kronborg   +23 more
doaj   +1 more source

Current Status and Influencing Factors of Decisional Conflict in Lung Cancer Patients Receiving Systemic Therapy: A Cross‐Sectional Analysis

open access: yesThoracic Cancer
Objective To investigate the current status of decisional conflict in lung cancer patients receiving systemic therapy and to analyze its influencing factors, with the aim of providing a basis for developing decision support strategies.
Weicai Su   +6 more
doaj   +1 more source

Evaluating First-line Chemotherapy Regimens and Platinum Choices in HER2-Negative Metastatic Gastric Cancer: A Retrospective Analysis

open access: yesJournal of Oncological Sciences
Objective: The survival advantage of triplet versus doublet chemotherapy regimens and cisplatin versus oxaliplatin-based therapies for first-line treatment in human epidermal growth factor receptor 2 (HER2)-negative metastatic gastric cancer remains ...
Caner ACAR   +5 more
doaj   +1 more source

Three‐Year Follow‐Up of the Phase II Trial for Resectable Non‐Small‐Cell Lung Cancer Treated With Perioperative Sintilimab and Neoadjuvant Anlotinib Plus Chemotherapy: TD‐NeoFOUR Trial

open access: yesThoracic Cancer
Background Lung cancer is a leading cause of cancer‐related deaths. Perioperative therapies, including neoadjuvant chemo‐immunotherapy, have improved outcomes, but combining them with antiangiogenic drugs may offer further benefits.
Zhiyuan Gao   +8 more
doaj   +1 more source

Is the Combination of Pembrolizumab and Regorafenib the Beginning of a New Era in the Treatment of Metastatic Colorectal Cancer?

open access: yesJournal of Oncological Sciences
Colorectal cancer is one of the most common lethal cancers worldwide. In the treatment of metastatic colorectal cancer (mCRC), survival rates have increased due to advancements in cytotoxic chemotherapy and targeted agents.
Aslı GEÇGEL   +3 more
doaj   +1 more source

Evaluation of additive electron beam melting of haynes 282 alloy

open access: yes, 2020
K. Unocic   +5 more
semanticscholar   +1 more source

Risk factors for refractive error after cataract surgery: Analysis of 282 811 cataract extractions reported to the European Registry of Quality Outcomes for cataract and refractive surgery.

open access: yesJournal of cataract and refractive surgery, 2018
M. Lundström   +7 more
semanticscholar   +1 more source

Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures.

open access: yesDiagnostic and Interventional Radiology, 2018
Hugo Jakobsson   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy